Given the importance of adherence to both lifestyle therapies and lipid-lowering medication
, the NLA advocates: 1) discussion of adherence at each patient visit to identify problems, barriers or side effects of therapy; 2) continuous feedback to patients about their non-HDL-C and LDL cholesterol levels and goals of these lipoproteins and 3) the incorporation, whenever possible, of an interdisciplinary team of healthcare providers-including nurses, nurse practitioners, clinical pharmacists, physician assistants and registered dietitian nutritionists-to assist patients with adherence issues.
The ALL initiative is a therapeutic program that includes the use of aspirin, lisinopril and a lipid-lowering medication
Also, participants prescribed with lipid-lowering medication
late into follow-up may have confounded results.
I prescribe lipid-lowering medication
, and I use metformin to treat insulin resistance.
Despite having received lipid-lowering medication
and diet therapy for at least six months, the patients' total cholesterol (TC) or triglyceride (TG) levels were still abnormal.
Among patients at risk, reducing the burden of atherogenic lipoproteins in serum with lipid-lowering medication
and lifestyle modification has been shown to reduce the risk for acute cardiovascular events in both the primary and secondary prevention settings.
In a recent study from Halifax, NS, Canada, older persons who were taking lipid-lowering medication
Is the patient taking any lipid-lowering medication
or were lipid-lowering medications
perhaps recently discontinued?
By study design none of the control participants received lipid-lowering medication
or took folate supplement or B vitamins.
Researchers controlled for a long list of possibly confounding factors, including segment location, length of follow-up, enrollment site, early angiography, baseline measures, age, education, diabetes, smoking, lipid-lowering medication
, and total energy intake.
For example, National Cholesterol Education Program guidelines call for contemplation of lipid-lowering medication
in patients with no conventional risk factors only if their LDL level exceeds 190 mg/dL; the target is an LDL level below 160 mg/dL.
LDL Particle Number (LDL-P) Distribution in Patients with Angiographic Coronary Artery Disease on Lipid-Lowering Medication
Lead presenter: Hector A.